https://aboutus.godaddy.net/newsroom/press-releases/press-release-details/2023/A-message-from-GoDaddy-CEO-Aman-Bhutani/default.aspx
Jefferies Initiates Coverage On Provention Bio with Buy Rating, Announces Price Target of $10
Jefferies analyst Chris Howerton initiates coverage on Provention Bio (NASDAQ:PRVB) with a Buy rating and announces Price Target of $10.